cardiac amyloidosis

Advertisement
Hirsh ElhenceHypertrophic Cardiomyopathy | May 2, 2023
As novel therapeutic agents such as Mavacamten and Tafamidis are developed and become clinically useful for patients ...
Rebecca AraujoOncology | March 31, 2023
Researchers from the Washington University School of Medicine developed a prediction model that may improve timely ...
Rebecca AraujoOncology | April 23, 2023
The ratio of left ventricular (LV) mass to electrocardiographic (EKG) voltage was associated with subsequent heart ...
Rebecca AraujoOncology | March 31, 2023
Right heart evaluation may be considered a marker for clinical risk stratification in patients with cardiac amyloidosis ...
Rebecca AraujoOncology | March 31, 2023
Findings published in Clinical Research in Cardiology showed that non-invasive cardiovascular magnetic resonance (CMR) ...
Rebecca AraujoOncology | July 5, 2023
Researchers from the Cedars-Sinai Medical Center found that cardiac transplantation can be safely performed in select ...
Rebecca AraujoOncology | March 31, 2023
A study published in the Journal of Nuclear Cardiology found that the 18F-flutemetamol positron emission tomography ...
Rebecca AraujoOncology | March 31, 2023
A study published in Blood Cancer Journal found that pleural effusion was strongly associated with poor right ...
DocWire News EditorsCardiology | November 6, 2020
Cardiopulmonary Exercise Testing Is Effective for Assessing Cardiac Amyloidosis ...
Rebecca AraujoThrombosis | September 6, 2023
In a study of patients with cardiac amyloidosis (CA), incidence rates of arterial thromboembolic events (AEs) were high, ...
Rebecca AraujoOncology | March 31, 2023
Cardiopulmonary exercise testing (CPET) was found to be helpful in assessing functional capacity, circulatory and ...
Rebecca AraujoLipid Management | May 2, 2023
Having low levels of high-density lipoprotein cholesterol (HDLC) has been identified as a novel serum biomarker for ...
DocWire News EditorsCardiology | April 13, 2023
Results from a new cohort study suggested an underdiagnosis of amyloidosis among black U.S. residents, as ...
Advertisement